Precautions for intensive adjuvant therapy after targeted adjuvant therapy for breast cancer

Intensive adjuvant therapy after targeted adjuvant therapy for

breast cancer is of great significance to further consolidate the efficacy. The following are some key considerations for drug use. First of all, it is the basic principle to use drugs on time and in accordance with medical supervision. Each drug has its own specific dosage and frequency of use, which is the best regimen based on a large number of clinical studies. For example, some oral targeted drugs may need to be taken at a fixed time every day, patients must strictly abide by, can not arbitrarily increase or decrease the dosage or interrupt medication, otherwise it may affect the therapeutic effect. The preservation conditions of drugs can not be ignored. Some drugs need to be refrigerated to ensure their activity and stability. For example, some new targeted agents are sensitive to temperature, which may lead to drug failure if they are not properly stored. After getting the medicine, the patient should ask the pharmacist carefully about the preservation method of the medicine and prepare the appropriate preservation equipment at home. It is important to pay close attention to adverse reactions during the use of drugs. Intensive adjuvant therapy may cause common adverse reactions such as nausea, vomiting, diarrhea, and rash. If there is slight discomfort, it can be alleviated by adjusting diet and keeping the skin clean. However, if serious adverse reactions, such as expiratory dyspnoea and panic, must be treated immediately, because this may be a serious allergic reaction or a signal of damage to vital organs of the body. Drug interactions also require attention. Patients may also have other diseases and are taking other medicines. Before starting intensive adjuvant therapy, they should inform their doctors of all medicines they are taking, including over-the-counter medicines and health care products. Some drugs may interact with breast cancer intensive adjuvant therapy drugs, affecting efficacy or increasing the risk of adverse reactions. Regular review is also a key link. By examining blood routine, liver and kidney function, imaging and other items, doctors can understand the impact of drugs on the body and the status of tumors. This will help to adjust the treatment plan in time to ensure the safety and effectiveness of the treatment. In a word, in the intensive adjuvant therapy after targeted adjuvant therapy for breast cancer, scientific and rational use of drugs is an important measure to ensure the rehabilitation of patients.